Researchers identify predator bacteria in microbiota of cystic fibrosis patients

For the first time, researchers have found the presence of predator bacteria in the microbiota of cystic fibrosis patients. There are researchers from Universidad Politécnica de Madrid among the authors of this finding.

The results, obtained by a team of researchers from Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria  (IRYCIS) and School of Agricultural, Food and Biosystems Engineering (ETSIAAB) at Universidad Politécnica de Madrid (UPM), have allowed them to design a computational model to eradicate the pathogens of cystic fibrosis lung by inoculating predator bacteria. The results have been published in mBio®, an open-access journal of the American Society for Microbiology.

The new technique of next-generation sequencing (NGS) gives evidence of the complexity in the lung microbiota, and also allows identifying a large number of bacteria unknown in cystic fibrosis lung patients so far.

UPM researchers from the group of Complex System were involved in this study that has used NGS tools to monitor the fluctuations of this ecosystem in 15 cystic fibrosis patients during a 1-year follow-up period, describing for the first time the presence of two predatory bacteria in the cystic fibrosis lung microbiome: Bdellovibrio and Vampirovibrio.

These to depredatory bacteria have led to develop a computational model based on agents where the behavior of the prey and predator are reproduced. The model initially presents 500 agents with five different species: two species with predator roles and three species with prey roles. By varying the initial amount of predators we achieve the classic solutions of the Lotka-Volterra type models: either total extinction of all species or coexistence of a predatory species and other prey species.

According to Javier Galeano, a researcher involved in this study, says: "The newly designed computational model allows us to hypothesize that inoculation of predators into the pulmonary microbiome might contribute to the control of chronic colonization by cystic fibrosis pathogens in early colonization stages".

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionizing MASLD treatment with GLP-1 receptor agonists